In cell culture analysis, angiostatin blocked overexpression of VEGF-A and TGF-β1 induced by high levels of glucose, while increasing the levels of pigment epithelium-derived factor (PEDF), an endogenous inhibitor of diabetic nephropathy. This evidence concerns the gene VEGFA and diabetic kidney disease.